Connecting the
Diabetes, Obesity, Metabolism and Complications Community
at Michigan
|
|
Scott Soleimanpour Featured on the Sugar Science Podcast |
|
|
|
the(sugar)science is a novel, non-profit digital platform helping scientists who study type 1 diabetes (T1D) connect, collaborate and gain funding for their best ideas. Our all-volunteer team, the majority with close connection to T1D, have received much positive support from the global population of scientists studying type 1 diabetes, as well as from Beyond Type 1, JDRF, HIRN and IPITA. Join
|
|
Childhood Obesity Research Core (CORC) Mini Grant Awards |
|
|
|
Through the Momentum Center, the Childhood Obesity Research Core (CORC), part of the Michigan Nutrition Obesity Research Center, funded 7 mini-grant projects with a total of 14 unique investigators from across the University of Michigan. The CORC mini-grant funding mechanism was designed to catalyze novel cross-disciplinary partnerships and strengthen childhood nutrition and overweight/obesity pilot research that could drive future NIH studies.
|
|
|
|
Clinical Excellence Society Inductee |
Congratulations to Andrew Kraftson, MD, Associate Professor of Internal Medicine, MEND Division, University of Michigan, for his induction into the 2021 Clinical Excellence Society. The Clinical Excellence Society recognizes in an ongoing fashion those faculty who, by their peers and their division, exude and demonstrate clinical excellence towards their patients and colleagues.
|
|
Continuous Glucose Monitoring, Paired with Low-Carb Diet Coaching in Adults with Prediabetes, Shows Promise in Driving Dietary Changes, Reversing Path to Diabetes |
|
More than 34 million Americans have diabetes and approximately 90-95% of them have type 2 diabetes, according to the CDC. The authors of a U-M study note that type 2 diabetes is preventable but that few patients with prediabetes take part in prevention measures.
|
|
|
MEND Caswell Diabetes Institute Grand Rounds Video |
|
|
|
Decio Eizirik, MD, PhD presents "Different yet similar? The Gene Expression Signature of Beta Cells in Type 1 Diabetes Compared to Target Tissues in Systemic Lupus Erythematosus, Multiple Sclerosis and Rheumatoid Arthritis"
|
|
Faculty Position in Metabolic Disease |
|
The Weill Center for Metabolic Health at Weill Cornell Medicine is seeking outstanding candidates for one or more full-time tenure-track basic scientist or physician-scientist faculty positions with research interests related to cellular or whole-body metabolism. We seek outstanding candidates at any rank with high-impact, cutting-edge research programs using physiological, molecular, and biochemical approaches to address critical questions in diabetes, obesity, and the interface between metabolism and other disorders. Generous startup resources are available. For physicians, a hospital appointment at NewYork-Presbyterian/Weill Cornell Medical Center will be available.
1. Cover letter
2. Curriculum Vitae
3. Brief overview of current and future research interests
4. Names and contact information of at least three referees
Letters of support should be sent separately, from the referees’ email addresses to:
|
|
2021 Steno North American Fellowships Accepting Applications |
|
|
|
Application Deadline is April 29, 2021, 2:00 p.m.
Steno is a transatlantic collaboration in clinical and health outcomes diabetes-related research, enhancing the synergies between the institutions for the benefit of people suffering from diabetes. The fellowship offers researchers the opportunity to dedicate from 3 months to 1.5 years to practice clinical and health outcomes diabetes-related research at a transatlantic partner institution.
|
|
|
|
2021 MCDTR Pilot and Feasibility Grant Program
Deadline: April 6, 2021
|
|
|
|
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 – Clinical Trial Optional)
Deadline: March 15, 2021
|
|
|
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements
|
|
|
|
Notice of Intent to Publish Research Opportunity Announcements (OTA-21-015) for the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative
|
|
About the Elizabeth Weiser Caswell Diabetes Institute
The University of Michigan has outstanding clinicians and researchers in diabetes, metabolic disorders, and their complications. The Elizabeth Weiser Caswell Diabetes Institute serves as the central hub to coordinate these programs. We work across disciplines and serve to integrate rigorous science with patient-centered clinical care to prevent, treat, and ultimately cure diabetes and related disorders.
|
|
Contact Us
Elizabeth Weiser Caswell Diabetes Institute
300 North Ingalls Building, Room 1135
Ann Arbor, Michigan 48109-5405
734-764-4433
Stay Informed
Did you receive this newsletter from a friend? Email us at
to be added to our mailing list.
|
|
|
If you have news items or events of interest to the diabetes, obesity, metabolism and complications community at Michigan, please tell us. Email us at
|
|
Supporting the Elizabeth Weiser Caswell Diabetes Institute |
|
Gifts to the Elizabeth Weiser Caswell Diabetes Institute are essential to our mission, to be at the forefront of cutting-edge research and to educate the next generation of leaders to be the best in medicine. Please consider supporting the Elizabeth Weiser Caswell Diabetes Institute: gifts can be made through multiple vehicles such as cash or securities, pledges, payroll deduct, etc. Our development partner, Andrea LaFave is happy to discuss and explore different options with you.
|
|
|
|
|
|
|
